Similar articles

• Prognostic and predictive biomarkers in renal cell carcinoma.

  Vickers MM, Heng DY. Vickers MM, et al. Target Oncol. 2010 Jun;5(2):85-94. doi: 10.1007/s11523-010-0143-8. Epub 2010 Jun 28. Target Oncol. 2010. PMID: 20582732 Review.
• Current status and future directions of molecular markers in renal cell carcinoma.

  Rini BI. Rini BI. Curr Opin Urol. 2006 Sep;16(5):332-6. doi: 10.1097/01.mou.0000240304.96131.44. Curr Opin Urol. 2006. PMID: 16905977 Review.
• Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

  Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA. Pantuck AJ, et al. Clin Cancer Res. 2003 Oct 15;9(13):4641-52. Clin Cancer Res. 2003. PMID: 14581333 Review.
• Biomarkers in renal cell carcinoma.

  McGuire BB, Fitzpatrick JM. McGuire BB, et al. Curr Opin Urol. 2009 Sep;19(5):441-6. doi: 10.1097/MOU.0b013e32832f0c68. Curr Opin Urol. 2009. PMID: 19584732 Review.
• VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.

  Montani M, Heinimann K, von Teichman A, Rudolph T, Perren A, Moch H. Montani M, et al. Am J Surg Pathol. 2010 Jun;34(6):806-15. doi: 10.1097/PAS.0b013e3181ddf54d. Am J Surg Pathol. 2010. PMID: 20431476